Channel - Research to Practice (R2P) Telehealth Webinars
12/18/2024 9:58:07 PM
Channel Videos
A New Era: Immunotherapy in Non-Small Cell Lung Cancer - C. Pecot - 2018221
This presentation describes the rationale behind using immunotherapy in lung cancer, the current standard of care use of immunotherapy, and future directions.
Chad Pecot MD
2/21/2018 4:30:00 PM
Advances in Head and Neck Cancer Management in North Carolina: Updates for 2021 - W. G. Yarbrough - 20210127
Wendell Yarbrough, MD, MMHC, FACS, will lecture on multi-disciplinary treatment of head and neck cancer with updates regarding new techniques and treatment standards. This lecture will also give the audience updates on HPV-Associated Head and Neck Cancer with emerging therapeutic vulnerabilities.
UNCCN Mediasite Presenter
1/27/2021 4:30:00 PM
Advances in Metastatic Prostate Cancer - M. Milowsky - 20160622
This lecture discusses some of the advancements in Metastatic Prostate Cancer such as the use of newer hormonal agents and Docetaxel chemotherapy against castration-sensitive metastatic prostate cancer.
Learning Outcomes:
• Discuss newer hormonal agents in the management of castration-resistant metastatic prostate cancer.
• Examine a new role for Docetaxel chemotherapy in the management of castration-sensitive metastatic prostate cancer.
• Compare other novel agents in the management of advanced prostate cancer.
This lecture was presented as a part of the Medical and Surgical Oncology Series.
Matthew Milowsky MD
6/22/2016 3:30:00 PM
Advances in Peri-Operative Therapy in Bladder and Kidney Cancer - T. L. Rose - 20220427
A comprehensive overview of past, present, and future management of systemic therapy for muscle-invasive bladder cancer and renal cell carcinoma. Includes updates on neoadjuvant and adjuvant therapy, as well as organ preservation techniques.
UNCCN Mediasite Presenter
4/27/2022 3:30:00 PM
Best of ASCO 2019: Breast and Gastrointestinal Cancers - A. McRee and E. Ray - 20190724
The American Society of Clinical Oncology (ASCO) hosts an annual conference that features some of the latest oncology research. Join us as our speaker highlights some of the top presentations from this year’s ASCO conference. This lecture focuses on the top research for Breast and Gastrointestinal Cancers at the 2019 ASCO conference.
UNCCN Mediasite Presenter
7/24/2019 3:30:00 PM
Best of ASCO 2019: Lung and Genitourinary Cancers - J. Weiss & T. Rose - 20190828
The American Society of Clinical Oncology (ASCO) hosts an annual conference that features some of the latest oncology research. Join us as our speaker highlights some of the top presentations from this year’s ASCO conference. This lecture focuses on the top research for Lung and Genitourinary Cancers at the 2019 ASCO conference.
UNCCN Mediasite Presenter
8/28/2019 3:21:00 PM
Breast Cancer Management in North Carolina: Updates for 2021 - Y. Abdou - 20210623
Yara Abdou, MD, from the UNC Lineberger Breast Oncology group will describe relevant updates in systemic therapy for breast cancers for health care providers throughout the state of North Carolina.
UNCCN Mediasite Presenter
6/23/2021 3:30:00 PM
Cardiovascular Toxicities of Cancer Therapies - Brian C. Jensen - 20221026
Brian Colwell Jensen, MD, will introduce the audience to potential cardiovascular adverse effects of contemporary cancer therapeutics.
UNCCN Mediasite Presenter
10/26/2022 5:05:55 PM
Clinical Trial Update in HPV Associated Oropharynx Cancer - B. Chera - 20191023
The Head and Neck Oncology program is actively pursuing a number of clinical trials at UNC. Dr. Bhisham S. Chera will provide an update on some of these trials.
UNCCN Mediasite Presenter
10/23/2019 3:30:00 PM
Demystifying Molecular-Based Tests in Head and Neck Cancers - S. Sheth - 20220928
Siddharth Sheth, DO, MPH, will provide a brief overview of clinical factors relevant to head and neck cancers and basic management. The main focus will be the current use of technologies that aid with the diagnosis, treatment selection, and monitoring of patients with head and neck cancers. This includes next-generation sequencing assays for DNA sequencing, RNA sequencing, and circulating tumor DNA. The goal of the presentation is for providers to be comfortable with ordering and basic interpretation of these tests.
UNCCN Mediasite Presenter
9/28/2022 3:30:00 PM
Genitourinary Cancer Management in North Carolina - M. I. Milowsky -20240925
Matthew I. Milowsky, MD, FASCO, will discuss aspects of bladder cancer including the role of biomarkers in the management of bladder cancer, the role of perioperative therapy for muscle-invasive bladder cancer, and treatment strategies for advanced/metastatic bladder cancer.
UNCCN Mediasite Presenter
9/25/2024 3:00:00 PM
GU Cancers: Best of ASCO - M. Milowsky - 20180425
UNCCN Mediasite Presenter
4/25/2018 3:30:00 PM
H. Pylori Testing and Treatment for Gastric Cancer Prevention - M. Epplein & K. Garman - 20231220
Katherine Garman, MD, and Meira Epplein, PhD, will provide information on gastric cancer and important risk factors such as H. pylori infection. We will describe some of the racial disparities associated with gastric cancer in the US, highlighting those that are relevant for North Carolina. We will also discuss H. pylori as a modifiable risk factor and we will review current guidelines on H. pylori testing, treatment, eradication testing, and the growing problem of antibiotic resistance.
UNCCN Mediasite Presenter
12/20/2023 4:30:00 PM
Head and Neck Cancer Management in North Carolina Updates for 2020 - S. Sheth - 20200422
Dr. Siddharth Sheth from the UNC Lineberger Head and Neck Oncology group will describe relevant updates in systemic therapy for head and neck cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
UNCCN Mediasite Presenter
4/22/2020 3:30:00 PM
Head and Neck Cancer: Treatment and Complications - J. G. Olson - 20170927
This presentation discussed integrative approaches to managing head and neck cancer and reviews available and emerging therapies for head and neck cancer, including concurrent, sequential, adjuvant, and palliative chemo-radiotherapy options. The content also highlights key changes to AJCC 8th edition.
Lecture Outcomes:
• Assess safety and efficacy of available therapies including immunotherapy in head and neck cancer.
• Assess safety and efficacy of emerging therapies including immunotherapy in head and neck cancer.
• Utilize strategies to optimally sequence available regimens for therapeutic management in head and neck cancer.
This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Juneko Grilley-Olson MD
9/27/2017 3:30:00 PM
HPV & Head/Neck Cancer - B. Chera and J. P. Zevallos - 20160127
This lecture will discuss the standard of care treatment of HPV positive oropharynx cancer, including the de-intensified and intensified treatment options. It will further examine the changing epidemiology of oropharyngeal squamous cell carcinoma as a result of the HPV infection.
Learning Outcomes:
• Discuss the standard of care options for treatment
• Discuss de-intensified and intensified treatment of HPV positive Oropharynx cancer
• Understand the changing epidemiology of oropharyngeal squamous cell carcinoma as a result of
human papillomavirus (HPV) infection
• Understand risk factors associated with HPV-positive oropharyngeal squamous cell carcinoma
• Understand the prognostic significance of HPV on oropharyngeal squamous cell carcinoma
This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series
Bhisham Chera MD
1/27/2016 4:30:00 PM
Immunological Mechanisms in Pancreatic Cancer - Y. P. Gupta - 20190327
This lecture will review the current understanding of the role of immune system in pancreatic cancer and provide insight into development of the latest immune-based therapies aimed at treating patients with pancreatic cancer.
UNCCN Mediasite Presenter
3/27/2019 3:30:00 PM
Impact of Patient Reported Outcomes on Patient Care - E. Basch - 20170524
This lecture will provide an overview of current news and advances in patient-reported outcomes research. Patient-reported outcomes includes assessment of patient symptoms, adverse events, functional status, and overall quality of life. The presentation will also discuss ways patient-reported outcomes can be used to assess and improve patient care specific to oncology patients.
Lecture Objectives:
-Explain the value of patient symptom reporting.
-Describe electronic communication systems for symptom management.
-Recognize national efforts to develop PRO systems in EHRs.
This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Ethan Basch MD
5/24/2017 3:30:00 PM
Improving Outcomes In Radical Cystectomy - R. S. Pruthi - 20190424
The lecture will evaluate the recent improvements in patients undergoing radical cystectomy for bladder cancer (including peri-operative chemotherapy and robotic surgery), and will describe some of the obstacles to providing optimal care that still exist.
Raj S. Pruthi, MD
4/24/2019 3:30:00 PM
Key Issues in Cancer Disparities and Outcomes Research - S. Wheeler - 20160928
This lecture discusses key elements related to cancer health disparities, including healthcare access and quality, patient outcomes, theoretical foundations, and potential drivers that create disparities. The presenter also provides examples of interventions and policies that can help reduce cancer health disparities, as well as, case studies applicable to current practice.
Learning Outcomes:
• Discuss patterns of cancer disparities in care access, quality, and outcomes.
• Identify potential drivers of cancer disparities.
• Describe how race/ethnicity and socioeconomic status are linked.
• Discuss potential solutions to mitigate cancer health disparities.
This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Stephanie Wheeler PhD, MPH
9/28/2016 3:30:00 PM
Leukemia Management in North Carolina: Updates for 2021 - M. Foster - 20211117
Matthew Foster, MD, from the UNC Lineberger Leukemia group will describe updates in the care of leukemias relevant in 2021
UNCCN Mediasite Presenter
11/17/2021 4:30:00 PM
Lung Cancer Management in North Carolina: Updates for 2022 - S. A. Patel - 20220323
Shetal A. Patel, MD, PhD will provide an update on recent data impacting the management of lung cancer.
UNCCN Mediasite Presenter
3/23/2022 3:30:00 PM
Managing Lung Cancer Heterogeneity - J. Akulian - 20180124
The most common lung cancers are known to have diverse pathological features and recent research has further identified distinct diseases with genetic and cellular heterogeneity. This lecture will provide strategies for managing this heterogeneity during clinical evaluation and treatment of patients.
Lecture Objectives:
Define lung cancer heterogeneity.
Discuss lung cancer heterogeneity.
Identify treatment decisions based on a patient's lung cancer heterogeneity.
UNCCN Mediasite Presenter
1/24/2018 4:30:00 PM
Mantle Cell Lymphoma Management in North Carolina: Updates for 2020 - C. Dittus - 20201118
Dr. Christopher Dittus from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for lymphomas for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
UNCCN Mediasite Presenter
11/18/2020 4:30:00 PM
Meeting the Unique Needs of Pediatric Oncology Patient - T. Alexander - 20180328
Every year, an estimated 250,000+ new cases of cancer affect children under the age of 20 worldwide. This presentation provides an overview of common pediatric oncology diseases, the general outcomes, and recent treatment advances.
John Alexander MD,MPH
3/28/2018 3:30:00 PM
Metastatic Breast Cancer - C. Dees - 20171213
This presentation discusses management of metastatic breast cancer. The presenter will provide a review of current systemic therapy options and will review advances in management strategies, including ongoing studies, for metastatic breast cancer.
Learning Outcomes:
• Understand systemic therapy options for HR+ Her2- metastatic breast cancer.
• Understand systemic therapy options for Her2+ metastatic breast cancer.
• Understand systemic therapy options for triple negative metastatic breast cancer.
This presentation is presented as part of Medical and Surgical Oncology Lecture series.
Claire Dees MD, MSc
12/13/2017 4:30:00 PM
Metastatic Breast Cancer - L. Carey - 20190626
Of women diagnosed with early-stage breast cancer, almost 30% will develop metastatic disease. Genomic testing of metastatic breast cancer will help us determine which forms of breast cancer are likely to return in other parts of the body.
Lisa Carey MD
6/26/2019 3:30:00 PM
North Carolina Cancer Challenge 2020: Improving Enrollment into Cancer Clinical Trials - E. Olsson & A. Bilheimer - 20201216
This lecture is an interactive presentation and discussion to consider barriers to cancer clinical trial enrollment in North Carolina and potential approaches to address this. Topics will include the importance of patient and provider engagement, education and resources for identifying research opportunities and available trials, barriers and mitigation strategies to address population disparities in trial enrollment, and other issues. This session aims to provide information and strategies on participant recruitment, allowing individual study teams and/or clinicians from across the state to determine how research best fits into their individual models and how to present research participation as an option to all patients.
UNCCN Mediasite Presenter
12/16/2020 4:30:00 PM
Novel Molecularly Targeted Therapies and Biomarkers in Advanced Colorectal Cancer - M. S. Lee - 20180725
Treatment of metastatic colorectal cancer has continued to evolve over the last several years, with emerging identification of biomarkers that underlie heterogeneity of responses to new and existing therapy. Ongoing clinical research seeks to identify new therapeutic options in molecularly-defined subgroups of patients. We will review the most exciting and clinically impactful research findings in this presentation.
Michael Lee ,MD
7/25/2018 3:30:00 PM
Obesity in Gynecologic Oncology: A Growing Epidemic - P. Gehrig - 20160224
The lecture will discuss the impact that obesity has on the development of gynecologic malignancies and the outcomes of those malignancies. Medical options for treating obesity will also be talked about as a preventative measure.
• Discuss the obesity epidemic in the United States.
• Assess the impact of obesity on the development of, and outcomes from, gynecologic malignancies.
• Compare and contrast the medical options for treating obesity as a preventative measure.
This lecture was presented as a part of the Medical and Surgical Oncology Series.
Paola Gehrig MD
2/24/2016 4:30:00 PM
PART I: The Role and Importance of HPV Infection in Head and Neck Cancer: T. Hackman - 20190522
Dr. Trevor Hackman is the Director of the Head and Neck Oncology Fellowship and specializes in treatment of patients with diseases and disorders of the ear, nose, throat (ENT), with a focus in head and neck oncology. In this lecture, he will talk about the Human Papillomavirus (HPV) in head and neck cancers in terms of epidemiology, vaccination, molecular/genomics, de-escalation, role of TORS, and immunotherapy.
Trevor Hackman MD,FACS
5/22/2019 3:30:00 PM
PART II: The Role and Importance of HPV Infection in Head and Neck Cancer: T. Hackman - 20190522
Dr. Trevor Hackman is the Director of the Head and Neck Oncology Fellowship and specializes in treatment of patients with diseases and disorders of the ear, nose, throat (ENT), with a focus in head and neck oncology. In this lecture, he will talk about the Human Papillomavirus (HPV) in head and neck cancers in terms of epidemiology, vaccination, molecular/genomics, de-escalation, role of TORS, and immunotherapy.
UNCCN Mediasite Presenter
5/22/2019 5:30:36 PM
Pharmacogenomics and Individual Therapy Research - F. Innocenti - 20161026
This lecture provides information on the advances in pharmacogenomic screening and its implication to clinical research and practice. The presentation reviews the use of genomics in clinical trials, determining the clinical utility of a genetic test, use of somatic DNA screening for drug therapy outside of oncology, and precision dosing of medications within oncology.
Learning Outcomes:
-Describe advances in screening for somatic mutations in tumor DNA.
-Identify implications of somatic DNA screens for drug therapy outside of oncology.
-Discuss precision dosing of cancer drugs.
This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Federico Innocenti MD, PhD
10/26/2016 3:30:00 PM
Primary CNS Lymphoma Management in North Carolina - C. Dittus - 20220727
Christopher Dittus, DO, MPH, from the UNC Lineberger Lymphoma group will describe relevant updates in systemic therapy for Primary Central Nervous System Lymphoma in North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
UNCCN Mediasite Presenter
7/27/2022 3:30:00 PM
Promising New Treatment Options for Rectal Cancer - K. Stitzenberg - 20170322
The information presented in this lecture is designed to assist the health care provider in understanding treatments for rectal cancer. This program will review the standard of care for rectal cancer based on staging and discuss emerging and investigational treatment paradigms.
Lecture Objectives:
-Discuss emerging treatment paradigms for rectal cancer with understanding of what is standard of care and what is still investigational.
-Discuss new surgical approaches to rectal cancer with understanding of what is standard of care and what is still investigational.
-Discuss the potential risks and benefits of emerging treatment paradigms.
This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Karyn Stitzenberg MD, MPH, FACS
3/22/2017 3:30:00 PM
Prostate Cancer Management in North Carolina: Updates for 2020 - Y. Whang - 20200122
Young Whang, MD, from the UNC Lineberger Genitourinary Oncology group will describe relevant updates in systemic therapy for prostate cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
Young Whang MD
1/22/2020 4:30:00 PM
Radiation Oncology in North Carolina: Updates for 2021 - D. Casey - 20211215
Dana Casey, MD, from the UNC Lineberger Radiation Oncology group will describe relevant updates in radiation oncology for health care providers throughout the state of North Carolina. This lecture will highlight updates in methods to increase the efficacy of radiation therapy, shorten treatment time, and minimize toxicity.
UNCCN Mediasite Presenter
12/15/2021 4:30:00 PM
Recent Advances on the Gut Microbiome and Cancer Therapy - T. O. Keku - 20180822
The gut microbiome is responsible for regulation of many functions in humans including metabolism, immune responses and inflammation. This lecture will focus on the gut microbiome and their interactions with the host to influence cancer treatment outcomes.
Temitope O. Keku PhD, MSPH
8/22/2018 3:30:00 PM
Renal Cell Carcinoma: Past, Present, and Future - T. Rose - 20170823
Information presented in this presentation is designed to increase knowledge about renal cell carcinoma (RCC). Information focuses on risk factors associated with RCC, the standard treatments for both localized and metastatic disease, and the future for RCC treatment.
Learning Outcomes:
• State the risk factors for kidney cancer, including the genetic syndromes associated with renal cell carcinoma.
• Discuss the current status of adjuvant treatment for high-risk localized kidney cancer.
• State the standard first- and second-line systemic therapies for metastatic kidney cancer.
This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Tracy Rose MD,MPH
8/23/2017 3:30:00 PM
Sarcoma Management in North Carolina: Updates for 2023 - M. Woodcock - 20230726
A broad overview of the multidisciplinary approaches for the treatment of soft tissue sarcomas in adults, and detailed updates in management with systemic therapies. Specific attention is paid to sarcoma sub-types which may warrant special considerations.
UNCCN Mediasite Presenter
7/26/2023 3:30:00 PM
Special Considerations for Patients and Mental Illness and Cancer - D. Rosenstein - 20160727
This lecture provides an overview of the critical role behavior has in oncology and discusses how to assess and manage psychiatric symptoms with a focus on suicide in cancer patients.
Learning Outcomes:
• Identify common challenges faced by psychiatric patients who are treated for cancer.
• Describe important drug-interactions with psychotropic medications.
• Employ sensitivity to previously traumatized patients.
This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Donald Rosenstein MD
7/27/2016 3:30:00 PM
The Role of Radiation Therapy in Advanced and Metastatic Disease - K. Pearlstein - 20171025
This presentation discusses common palliative radiation treatments, techniques, and toxicities. The content reviews current guidelines for the use of radiation in advanced and metastatic disease as well as oligometastatic disease.
Learning Outcomes:
• Identify symptoms that can be effectively treated with palliative radiotherapy and describe common palliative treatment approaches.
• Recognize the role of radiation in providing local control for locally advanced and oligometastatic disease.
• Recognize acute and late toxicities of radiotherapy for different treatment sites.
This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Kevin Pearlstein MD
10/25/2017 3:30:00 PM
Thoracic Surgical Oncology - G. Mody - 20210728
Thoracic surgery is an integral part of the multidisciplinary management of patients with lung cancer. This lecture discusses approaches to lung tumor resection and areas of future investigation in treatment of advanced lung cancer.
UNCCN Mediasite Presenter
7/28/2021 3:30:00 PM
Topics in Cancer Pharmacy in North Carolina: Updates for Oral Chemotherapy for 2022 - B. Patel - 20220622
Bianka Patel, PharmD, BCOP, CPP, is a clinical pharmacist at UNC Medical Center. She went to pharmacy school at UNC and did her second year of pharmacy training in oncology at UNC and stayed on in a role as outpatient hematology/oncology float pharmacist. Because of this role, she has experience covering various adult oncology clinics and has the opportunity to support patients on oral chemotherapy agents as part of the role.
UNCCN Mediasite Presenter
6/22/2022 3:30:00 PM
Treatment of Relapsed and Refractory Multiple Myeloma - B. Reeves - 20170628
Purpose:
This presentation discusses current strategies for managing relapsed and refractory multiple myeloma. Update are provided on appropriate chemotherapy regimens for relapsed and refractory multiple myeloma, including new options of treatment for this disease. The presentation also reviews factors influencing treatment, including when treatment should be initiated and discontinued.
Learning Outcomes:
-Determine when to start treatment in the context of relapsed multiple myeloma.
-Identify appropriate chemotherapy regimens for relapsed multiple myeloma.
-Understand new drugs in clinical trial for relapsed and refractory multiple myeloma.
This lecture was presented as part of the Medical and Surgical Oncology Lecture Series.
Brandi Reeves MD
6/28/2017 3:30:00 PM
Tumor Treating Fields for Glioblastoma - Simon Khagi - 20180926
Glioblastoma is a devastating disease with a survival that is measured in months. The recent FDA approval of the Optune device for the treatment of newly-diagnosed glioblastoma was a paradigm shift in the field of neuro-oncology. We will focus our discussion on the biological underpinnings of this device and clinical data supporting its use.
Simon Khagi, MD
9/26/2018 3:30:00 PM
Update on CAR T Therapy - N. Grover - 20181219
This lecture will give an overview of CAR-T cells, discuss recent clinical trial results and FDA approvals as well as current clinical applications. This lecture will also cover the management of the unique toxicities of CAR-T therapy. Finally, this lecture will discuss some of the ongoing trial of CAR-T therapy as well as future directions of the field.
For continuing education credits for this and other lectures, please visit our Learning Portal at learn.unc.org.
UNCCN Mediasite Presenter
12/19/2018 4:30:00 PM
Updates in Breast Cancer Epidemiology and Pathogenesis - M. Troester - 20160427
This lecture will discuss the latest research in the scope of epidemiology and pathology to gain a better understanding of both the survivorship and causes of breast cancer. Dr. Troester will focus on mortality disparities in races and the research challenges for resolving these disparities.
Learning Outcomes:
• Describe the subtypes of breast cancer and how they are identified with tissue biomarkers.
• Illustrate differences in risk factor and survivorship profiles for breast cancer subtypes.
• Describe racial disparities in incidence and mortality from cancer and highlight remaining research challenges for understanding and resolving disparities.
This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Melissa Troester PhD
4/27/2016 3:30:00 PM
Updates in Lung Cancer from ASCO 2016 - J. Weiss - 20160824
This lecture provides a review of 2016 updates from the American Society of Clinical Oncology and includes recognizing new treatment plans for patients with lung cancer, how intensive follow-up can improve the quality of life and survival for thoracic oncology patients, and using American Joint Committee on Cancer (AJCC) in treatment planning.
Learning Outcomes:
• Recognize new treatments that are available for metastatic lung cancer, localized lung cancer, and small cell lung cancer.
• Describe the role that intensive follow-up can play in improving quality of life and survival for thoracic oncology patients.
• Discuss use of American Joint Committee on Cancer (AJCC) in treatment planning to ensure appropriate prognostic indicators and evidence-based national guidelines are used when developing treatment plans for thoracic oncology patients.
This lecture was presented as a part of the Medical and Surgical Oncology Lecture Series.
Jared Weiss MD
8/24/2016 3:30:00 PM
Using Biomarkers to Plan Adjuvant Therepy in Breast Cancer - L. A. Carey - 20180627
It is difficult to determine whether a primary therapy has suppressed or killed a cancer. Adjuvant therapy can further improve the chances that the cancer will not return. In this presentation Dr. Cary will discuss which adjuvant therapy options are available for breast cancer patients as well as some of the recent developments in adjuvant therapy.
UNCCN Mediasite Presenter
6/27/2018 3:30:00 PM
Mediasite Showcase
Mediasite's the trusted cornerstone of any campus or enterprise video strategy. Our unyielding commitment to all things video helps you transform education, training, communications and online events.
Webcasting Video Content Management Video Delivery Integration Services Mediasite Community
Powered By Mediasite - Enterprise Video Platform